Press release
Irritable Bowel Syndrome (IBS) Treatment Market: Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth. IBS is a common chronic condition that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than inflammatory bowel disease. It shows symptoms such as cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both at the same. If the symptoms are mild, they can be managed by changing stress, lifestyle, and diet. On the other side, severe symptoms are treated with medication and counseling.The irritable bowel syndrome (IBS) treatment market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028.
Request for sample research at: https://www.theinsightpartners.com/sample/TIPRE00006814/?openpr-10144
Ironwood Pharmaceuticals, Inc.; AbbVie.; Sebela Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Alfasigma S.p.A.; Astellas Pharma Inc.; AstraZeneca; Synthetic Biologics, Inc.; Bausch + Lomb Incorporated; and Lannett Company Inc are among the leading companies operating in the market.
Based on type, the irritable bowel syndrome (IBS) treatment market is segmented into mixed IBS (IBS-M), IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C). The mixed IBS (IBS-M) segment held the largest share of the market in 2020. Also, the same segment is expected to register the highest CAGR during 2021–2028. In the coming years, the rising prevalence of IBS among women and men is anticipated to propel the demand for the medicines that can treat combined symptoms of constipation and diarrhea. According to updated Rome IV criteria, the reverse condition of IBS-M is described as a model of hard or irregular stools in more than 25% of bowel movements. The prevalence is higher in the geriatric population. Therefore, the demand for medicines to treat mixed IBS is likely to grow significantly during the forecast period,
Irritable bowel syndrome is a majorly observed chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping. Health systems across the regions are witnessing considerable growth in the incidence of irritable bowel syndrome. A data published by International Foundation for Gastrointestinal Disorders states that among all IBS patients, about 40% patients have mild IBS, around 35% have moderate IBS, and an estimated 25% suffer from severe IBS. Many people don't recognize IBS symptoms.
Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that can cause IBS. These factors are projected to accelerate the rate of IBS prevalence across the world. For instance, according to a study published on NCBI in 2018, IBS is estimated to affect around 10% to 16% of the US population each year. Such staggering prevalence of IBS is likely to boost the irritable bowel syndrome (IBS) treatment market during the forecast period.
Purchase Full copy of This Report at: https://www.theinsightpartners.com/buy/TIPRE00006814/?openpr-10144
Irritable Bowel Syndrome (IBS) Treatment Market – by Type
IBS with Diarrhea (IBS-D)
IBS with Constipation (IBS-C)
Mixed IBS (IBS-M)
Irritable Bowel Syndrome (IBS) Treatment Market – by Product
Rifaximin
Eluxadoline
Linaclotide
Lubiprostone
Others
Irritable Bowel Syndrome (IBS) Treatment Market – by Distribution Channel
Hospitals Pharmacies
Drug Stores and Retail Pharmacies
Online Pharmacies
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Phone: +1-646-491-9876
Email- sales@theinsightpartners
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome (IBS) Treatment Market: Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions here
News-ID: 2325187 • Views: …
More Releases from The Insight Partners

RF Front End Module Market Emerging Technological Growth, Future Growth and Busi …
The RF front end module market size is projected to reach US$ 7.58 billion by 2031 from US$ 3.89 billion in 2024. The market is expected to register a CAGR of 10.3% during 2025-2031.
The "RF Front End Module Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. RF Front End Module Market report offers an in-depth analysis on segments including top companies, products,…

Collagen Supplements Market Demand Analysis and Projected huge Growth by 2031
The "Collagen Supplements Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Collagen Supplements Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leading…

Refrigeration Coolers Market Research Report Explores the Trade Trends for the F …
The Refrigeration Coolers Market is expected to register a CAGR of 6.4% from 2025 to 2031, with a market size expanding from US$ 4.50 billion in 2024 to US$ 7.48 billion by 2031.
The "Refrigeration Coolers Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Refrigeration Coolers Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number…

Unlocking Opportunities in the SGP Interlayer Films Market: Market Forecast, Key …
In the world of advanced glazing, SGP interlayer films represent a high-performance ionic interlayer inserted between glass panes. Thanks to superior strength, clarity, and safety characteristics, SGP films are gaining traction in applications from architecture to automotive safety. The Insight Partners forecasts the global SGP Interlayer Films Market to grow at a 6% CAGR between 2025 and 2031.
This press release examines how market participants are strategizing for growth, whom the…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning.
This also includes consulting services concerning railway systems issues, such as travel…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…